Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis

American Journal Of Pathology (2001) - Comments
pubmed: 11238046 issn: 0002-9440 doi: 10.1016/s0002-9440(10)64045-x

Ginesa Garcia-Rostan, Robert L. Camp, Agustin Herrero, Maria Luisa Carcangiu, David L. Rimm, Giovanni Tallini